Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,989 | 425 | 98.2% |
| Education | $116.55 | 4 | 1.6% |
| Entertainment | $13.15 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,250 | 84 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $693.98 | 39 | $0 (2024) |
| Amgen Inc. | $650.62 | 40 | $0 (2024) |
| Lilly USA, LLC | $574.32 | 37 | $0 (2024) |
| Novo Nordisk Inc | $518.94 | 39 | $0 (2024) |
| PFIZER INC. | $471.41 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $359.74 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $332.72 | 24 | $0 (2024) |
| Amarin Pharma Inc. | $305.68 | 20 | $0 (2022) |
| Astellas Pharma US Inc | $281.95 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $704.06 | 37 | AstraZeneca Pharmaceuticals LP ($101.58) |
| 2023 | $613.03 | 33 | Lilly USA, LLC ($155.25) |
| 2022 | $933.45 | 54 | Amgen Inc. ($135.92) |
| 2021 | $1,220 | 74 | Amgen Inc. ($178.68) |
| 2020 | $691.49 | 44 | AstraZeneca Pharmaceuticals LP ($205.28) |
| 2019 | $733.68 | 42 | AstraZeneca Pharmaceuticals LP ($218.16) |
| 2018 | $1,132 | 72 | AstraZeneca Pharmaceuticals LP ($215.98) |
| 2017 | $1,091 | 74 | AstraZeneca Pharmaceuticals LP ($271.66) |
All Payment Transactions
430 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: VACCINE | ||||||
| 08/19/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Obesity | ||||||
| 07/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $47.51 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Neuroscience | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: WOMENS HEALTH | ||||||
| 05/15/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $28.54 | General |
| Category: Medical Device | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/28/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: WOMENS HEALTH | ||||||
| 03/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,923 | 3,966 | $339,290 | $139,989 |
| 2022 | 27 | 3,039 | 5,474 | $440,855 | $202,811 |
| 2021 | 26 | 2,839 | 5,838 | $456,260 | $217,116 |
| 2020 | 19 | 2,312 | 3,453 | $300,985 | $117,942 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 348 | 770 | $77,000 | $40,662 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 377 | 453 | $65,685 | $30,618 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 196 | 196 | $39,200 | $23,251 | 59.3% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 38 | 38 | $11,400 | $9,169 | 80.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 334 | 367 | $37,475 | $7,262 | 19.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 366 | 686 | $17,150 | $5,754 | 33.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 95 | 95 | $3,800 | $3,115 | 82.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 81 | 81 | $25,920 | $2,738 | 10.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 94 | 94 | $2,820 | $2,685 | 95.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 21 | 21 | $3,675 | $2,616 | 71.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 262 | 274 | $19,440 | $2,368 | 12.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,600 | $2,015 | 77.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 393 | 534 | $10,680 | $1,811 | 17.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 57 | 58 | $2,900 | $1,674 | 57.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 94 | 96 | $8,160 | $1,498 | 18.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 20 | $1,400 | $546.48 | 39.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 65 | $3,250 | $520.49 | 16.0% |
| 72050 | X-ray of upper spine, 4-5 views | Office | 2023 | 11 | 11 | $1,400 | $422.18 | 30.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 26 | $1,300 | $393.18 | 30.2% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 12 | 12 | $1,920 | $369.50 | 19.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,265 | $302.64 | 23.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 30 | 32 | $800.00 | $160.98 | 20.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 13 | 13 | $50.12 | $39.42 | 78.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 376 | 697 | $101,065 | $52,364 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 369 | 912 | $91,200 | $51,353 | 56.3% |
About Dr. Cheri Vachtsevanos, MD
Dr. Cheri Vachtsevanos, MD is a Internal Medicine healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609844067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cheri Vachtsevanos, MD has received a total of $7,119 in payments from pharmaceutical and medical device companies, with $704.06 received in 2024. These payments were reported across 430 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,989).
As a Medicare-enrolled provider, Vachtsevanos has provided services to 11,113 Medicare beneficiaries, totaling 18,731 services with total Medicare billing of $677,858. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Gainesville, GA
- Active Since 03/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609844067
Products in Payments
- FARXIGA (Drug) $832.74
- JARDIANCE (Drug) $606.96
- Vascepa (Drug) $305.68
- TRULICITY (Drug) $274.16
- HETLIOZ (Drug) $256.23
- Aimovig (Biological) $217.57
- MOUNJARO (Drug) $201.76
- JANUVIA (Drug) $161.55
- Ozempic (Drug) $159.69
- INVOKANA (Drug) $150.59
- SYMBICORT (Drug) $149.02
- ELIQUIS (Drug) $146.08
- MYRBETRIQ (Drug) $138.88
- Kerendia (Drug) $133.09
- Victoza (Drug) $122.69
- CHANTIX (Drug) $112.89
- Catalyst Total CSR (Device) $111.68
- EVENITY (Biological) $111.14
- XARELTO (Drug) $110.80
- Prolia (Biological) $96.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gainesville
Dr. Vivek Sambhara, M.d, M.D
Internal Medicine — Payments: $217,213
Dr. Christopher Recknor, M.d, M.D
Internal Medicine — Payments: $91,144
Dr. Carlos Alviar Restrepo, Md, MD
Internal Medicine — Payments: $90,926
Dr. Alanna Morris, M.d, M.D
Internal Medicine — Payments: $85,602
Brian Ramnaraign, M.d, M.D
Internal Medicine — Payments: $65,740
Ilie Barb, M.d, M.D
Internal Medicine — Payments: $55,024